Terms: = Gastric cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
433 results:
1. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
2. Xianglian Pill combined with 5-fluorouracil enhances antitumor activity and reduces gastrointestinal toxicity in gastric cancer by regulating the p38 MAPK/NF-κB signaling pathway.
Yu L; Qin JY; Sun C; Peng F; Chen Y; Wang SJ; Tang J; Lin ZW; Wu LJ; Li J; Cao XY; Li WQ; Xie XF; Peng C
J Ethnopharmacol; 2024 May; 326():117988. PubMed ID: 38428657
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer Effects of
Han EJ; Choi EY; Jeon SJ; Moon JM; Lee SW; Lee JH; Jung GH; Han SH; Jung SH; Yang MS; Jung JY
J Med Food; 2024 Apr; 27(4):330-338. PubMed ID: 38387002
[TBL] [Abstract] [Full Text] [Related]
4. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the erk1/2 and JAK/STAT pathways.
Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
[TBL] [Abstract] [Full Text] [Related]
5. Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.
Peng Y; Lei X; Yang Q; Zhang G; He S; Wang M; Ling R; Zheng B; He J; Chen X; Li F; Zhou Q; Zhao L; Ye G; Li G
Exp Mol Med; 2024 Feb; 56(2):441-452. PubMed ID: 38383581
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
Hosseini SA; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Epigenomics; 2024 Mar; 16(5):277-292. PubMed ID: 38356395
[TBL] [Abstract] [Full Text] [Related]
7. Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells.
Su BC; Chen GY; Yang CM; Chuang WT; Lin MC; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Yu HH
Int J Hyperthermia; 2024; 41(1):2310017. PubMed ID: 38350654
[No Abstract] [Full Text] [Related]
8. Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways.
Liu J; Li SM; Tang YJ; Cao JL; Hou WS; Wang AQ; Wang C; Jin CH
Redox Rep; 2024 Dec; 29(1):2313366. PubMed ID: 38318818
[TBL] [Abstract] [Full Text] [Related]
9. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
[TBL] [Abstract] [Full Text] [Related]
10. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.
Che K; Luo Y; Song X; Yang Z; Wang H; Shi T; Wang Y; Wang X; Wu H; Yu L; Liu B; Wei J
EMBO Mol Med; 2024 Feb; 16(2):251-266. PubMed ID: 38238529
[TBL] [Abstract] [Full Text] [Related]
11. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract] [Full Text] [Related]
12. Loss of keratin 23 enhances growth inhibitory effect of melatonin in gastric cancer.
Li L; Lin M; Luo J; Sun H; Zhang Z; Lin D; Chen L; Feng S; Lin X; Zhou R; Song J
Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38099343
[TBL] [Abstract] [Full Text] [Related]
13. Investigating the therapeutic mechanism of Xiaotan Sanjie Formula for gastric cancer via network pharmacology and molecular docking: A review.
Xu X; Yu Z; Zeng S
Medicine (Baltimore); 2023 Nov; 102(46):e35986. PubMed ID: 37986339
[TBL] [Abstract] [Full Text] [Related]
14. Regulatory roles of ACSL5 in the anti-tumor function of palmitic acid (C16:0) via the erk signaling pathway.
Lv J; Yanting W; Wei S
Eur J Histochem; 2023 Nov; 67(4):. PubMed ID: 37946526
[TBL] [Abstract] [Full Text] [Related]
15. FLOT1 promotes gastric cancer progression and metastasis through BCAR1/erk signaling.
Wang R; Huang W; Cai K; Xiao S; Zhang W; Hu X; Guo J; Mao L; Yuan W; Xu Y; Chen Z; Chen Z; Lai C
Int J Biol Sci; 2023; 19(16):5104-5119. PubMed ID: 37928269
[TBL] [Abstract] [Full Text] [Related]
16. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
Beyer GV; Hueser S; Li R; Manika D; Lee M; Chan CHF; Howe JR; Ear PH
Surgery; 2024 Mar; 175(3):605-612. PubMed ID: 37914572
[TBL] [Abstract] [Full Text] [Related]
17. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
[TBL] [Abstract] [Full Text] [Related]
18. Targeting Stem Cells and Dysplastic Features With Dual MEK/erk and STAT3 Suppression in gastric Carcinogenesis.
Kim H; Jang B; Zhang C; Caldwell B; Park DJ; Kong SH; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2024 Jan; 166(1):117-131. PubMed ID: 37802423
[TBL] [Abstract] [Full Text] [Related]
19. Radiation-induced gastric injury during radiotherapy: molecular mechanisms and clinical treatment.
Chen G; Yu Z; Zhang Y; Liu S; Chen C; Zhang S
J Radiat Res; 2023 Nov; 64(6):870-879. PubMed ID: 37788485
[TBL] [Abstract] [Full Text] [Related]
20. DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/erk activity in gastric cancer cells.
Chen Z; Zhang L; Yang Y; Liu H; Kang X; Nie Y; Fan D
Epigenetics; 2023 Dec; 18(1):2254976. PubMed ID: 37691391
[TBL] [Abstract] [Full Text] [Related]
[Next]
